Search Results

There are 35074 results for: content related to: Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?

  1. You have free access to this content
    Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists

    BJU International


    Version of Record online : 17 MAR 2006, DOI: 10.1111/j.1464-410X.2006.06066.x

  2. You have free access to this content
    Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer

    BJU International

    Volume 101, Issue 9, May 2008, Pages: 1096–1100, Yasuhisa Fujii, Junji Yonese, Satoru Kawakami, Shinya Yamamoto, Yuhei Okubo and Iwao Fukui

    Version of Record online : 8 JAN 2008, DOI: 10.1111/j.1464-410X.2007.07374.x

  3. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer

    Intervention Review

    The Cochrane Library

    Rekha Wuntakal, Srividya Seshadri, Ana Montes and Geoff Lane

    Published Online : 29 JUN 2016, DOI: 10.1002/14651858.CD011322.pub2

  4. You have free access to this content
    Gonadotropin-releasing hormone: An update review of the antagonists versus agonists

    International Journal of Urology

    Volume 19, Issue 7, July 2012, Pages: 594–601, Hein Van Poppel and Laurence Klotz

    Version of Record online : 14 MAR 2012, DOI: 10.1111/j.1442-2042.2012.02997.x

  5. You have free access to this content
    Protecting spermatogenesis from damage induced by doxorubicin using the luteinizing hormone-releasing hormone agonist leuprorelin


    Volume 79, Issue 5, 1 March 1997, Pages: 1014–1021, Fumio Manabe, Hitoshi Takeshima and Hideyuki Akaza

    Version of Record online : 28 SEP 2000, DOI: 10.1002/(SICI)1097-0142(19970301)79:5<1014::AID-CNCR19>3.0.CO;2-4

  6. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women

    Intervention Review

    The Cochrane Library

    Shom Goel, Rohini Sharma, Anne Hamilton and Jane Beith

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD004562.pub4

  7. You have free access to this content
    Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer

    Intervention Review

    The Cochrane Library

    Frank Kunath, Henrik R Grobe, Gerta Rücker, Edith Motschall, Gerd Antes, Philipp Dahm, Bernd Wullich and Joerg J Meerpohl

    Published Online : 30 JUN 2014, DOI: 10.1002/14651858.CD009266.pub2

  8. You have free access to this content
    The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

    BJU International

    Volume 102, Issue 11, December 2008, Pages: 1531–1538, Laurence Klotz, Laurent Boccon-Gibod, Neal D. Shore, Cal Andreou, Bo-Eric Persson, Per Cantor, Jens-Kristian Jensen, Tine Kold Olesen and Fritz H. Schröder

    Version of Record online : 21 NOV 2008, DOI: 10.1111/j.1464-410X.2008.08183.x

  9. You have free access to this content
    Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1200–1208, Santiago Vilar González and Xavier Maldonado Pijuan

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09827.x

  10. You have free access to this content
    Androgen deprivation therapy: past, present and future

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 1–12, F. Schröder, E.D. Crawford, K. Axcrona, H. Payne and T.E. Keane

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11215.x

  11. You have full text access to this Open Access content
    Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by leuprorelin, a luteinizing hormone–releasing hormone agonist

    Cancer Science

    Volume 97, Issue 6, June 2006, Pages: 459–467, Mahmoud M. Said, Naomi Hokaiwado, Mingxi Tang, Kumiko Ogawa, Shugo Suzuki, Hala M. Ghanem, Amr Y. Esmat, Makoto Asamoto, Fawzia M. Refaie and Tomoyuki Shirai

    Version of Record online : 26 MAY 2006, DOI: 10.1111/j.1349-7006.2006.00213.x

  12. You have free access to this content
    Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer

    BJU International

    Volume 92, Issue 3, August 2003, Pages: 226–231, C.F. Heyns, M.-P. Simonin, P. Grosgurin, R. Schall, H.C. Porchet and for the South African Triptorelin Study Group

    Version of Record online : 23 JUL 2003, DOI: 10.1046/j.1464-410X.2003.04308.x

  13. In vivo evaluation and in vitro metabolism of leuprolide in mice—mass spectrometry-based biomarker measurement for efficacy and toxicity

    Journal of Mass Spectrometry

    Volume 43, Issue 10, October 2008, Pages: 1381–1392, Zacharias D. Sofianos, Theodora Katsila, Nikolaos Kostomitsopoulos, Vaggelis Balafas, John Matsoukas, Theodoros Tselios and Constantin Tamvakopoulos

    Version of Record online : 28 APR 2008, DOI: 10.1002/jms.1416

  14. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis

    Intervention Review

    The Cochrane Library

    Julie Brown, Alice Pan and Roger J Hart

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD008475.pub2

  15. Prostate Cancer

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt015

  16. Adrenal responsiveness to high, low and very low ACTH 1–24 doses in obesity

    Clinical Endocrinology

    Volume 53, Issue 4, October 2000, Pages: 437–444, M. Maccario, S. Grottoli, L. DiVito, R. Rossetto, F. Tassone, C. Ganzaroli, S. E. Oleandri, E. Arvat and E. Ghigo

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2265.2000.01120.x

  17. You have free access to this content
    Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population


    Volume 112, Issue 10, 15 May 2008, Pages: 2195–2201, Christopher J. Weight, Eric A. Klein and J. Stephen Jones

    Version of Record online : 7 APR 2008, DOI: 10.1002/cncr.23421

  18. You have free access to this content
    Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer

    BJU International

    Volume 104, Issue 11, December 2009, Pages: 1580–1584, Roger S. Kirby, John M. Fitzpatrick and Noel Clarke

    Version of Record online : 10 NOV 2009, DOI: 10.1111/j.1464-410X.2009.08924.x

  19. Maximal androgen blockade for advanced prostate cancer

    Intervention Review

    The Cochrane Library

    Brian Schmitt, Charles Bennett, Jerome Seidenfeld, David Samson and Timothy J Wilt

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD001526

  20. Nimodipine inhibits TMB-8 potentiation of AMPA-induced hippocampal neurodegeneration

    Journal of Neuroscience Research

    Volume 87, Issue 5, April 2009, Pages: 1240–1249, Fabián Bernal, Valerie Petegnief, Manuel José Rodríguez, Gloria Ursu, Marco Pugliese and Nicole Mahy

    Version of Record online : 11 NOV 2008, DOI: 10.1002/jnr.21930